Last reviewed · How we verify

NCT03360097: LATEBLOOM

Clinical Outcomes of Slow Developing Blastocysts

Terminated NA Last updated 1 June 2018
What this trial tests

NA trial testing Frozen Embryo Transfer in Infertility in 2 participants. Terminated before completion.

Timeline
1 December 2017
Primary endpoint
30 May 2018
30 May 2018

Quick facts

Lead sponsorFundacion Dexeus
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment2
Start date1 December 2017
Primary completion30 May 2018
Estimated completion30 May 2018
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Fundacion Dexeus — full company profile →

Who can join

Adults 18 to 44, female only, with Infertility. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates which transfer strategy will result in a higher probability of pregnancy in patients whose single best day 5 embryo resulting from an IVF cycle is classified as expansion grade \<4 by Gardner and Schoolcraft classification. All cycles will be cultured to day 6 and half the patients will undergo a fresh embryo transfer and the other half a frozen embryo transfer.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Infertility

Currently open trials in the same condition.

Other Fundacion Dexeus trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03360097.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing